A novel investigational endoscopic procedure targeting the duodenum appears beneficial in improving glycemic parameters in ...

The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity. Increasingly, ...

Weight-loss medications such as Ozempic, Wegovy, and Mounjaro have attracted widespread attention, making headlines across ...

Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

Mounjaro is a prescription injection, often used off-label for weight loss, that is administered under the skin to patients struggling with obesity and weight loss. Off-label means that the actual use ...

Participants were randomly assigned either to escalation of dulaglutide to 4.5 mg or maximum tolerated dose (MTD), or to ...

Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...